Targeting Inhibitors of the Tumor Suppressor PP2A for the Treatment of Pancreatic Cancer

Pancreatic cancer is a deadly disease that is usually diagnosed in the advanced stages when few effective therapies are available. Given the aggressive clinical course of this disease and lack of good treatment options, the development of new therapeutic agents for the treatment of pancreatic cancer...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Farrell, Amy S., Allen-Petersen, Brittany, Daniel, Colin J., Wang, Xiaoyan, Wang, Zhiping, Rodriguez, Sarah, Impey, Soren, Oddo, Jessica, Vitek, Michael P., Lopez, Charles, Christensen, Dale J., Sheppard, Brett, Sears, Rosalie C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4116560/
https://ncbi.nlm.nih.gov/pubmed/24667985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-13-0542
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller